SEC Form 4 · accession 0001562180-17-001448
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hippel
Officer — Chief Financial Officer
Period of report
Mar 31, 2017
Accepted (ET)
Apr 4, 2017 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 31, 2017 | F | 800 | $101.65 | D | 3,079 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F3 | — | holding | — | — | — | — | — | Common Stock | 4,925 | 4,925 | D |
| Restricted Stock UnitF2,F4 | — | holding | — | — | — | — | — | Common Stock | 3,000 | 3,000 | D |
| Stock Option (Right to Buy)F4 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 18,750 | 18,750 | D |
| Stock Option (Right to Buy)F5 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 30,400 | 30,400 | D |
| Stock Option (Right to Buy)F6 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 35,000 | 35,000 | D |
| Stock Option (Right to Buy)F7 | $86.25 | holding | — | — | — | — | Apr 1, 2021 | Common Stock | 10,000 | 10,000 | D |
| Stock Options (Right to buy)F8 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 25,000 | 25,000 | D |
| Stock Options (Right to buy)F9 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 40,533 | 40,533 | D |
| Stock Options (Right to buy)F10 | $86.25 | holding | — | — | — | — | Apr 1, 2021 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The reporting person has elected to satisfy his withholding obligation in connection with the vesting of a prior restricted stock unit grant by directing the Company to withhold shares otherwise issuable pursuant to the previously reported grant.
- F106,250 shares vest on each of 4/1/15, 4/1/16, 4/1/17 and 4/1/18.
- F2Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
- F3Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)
- F4Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)
- F5Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F68,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
- F7Vests in full or in part if certain performance goals are achieved.
- F86,250 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- F9Vests 10,134 shares on 8/18/17, and 10,133 shares on each of 8/18/18, 8/18/19 and 8/18/20.